175 related articles for article (PubMed ID: 26850493)
1. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.
Andersen MA; Vojdeman FJ; Andersen MK; Brown Pde N; Geisler CH; Weis Bjerrum O; Niemann CU
Leuk Lymphoma; 2016 Jul; 57(7):1592-9. PubMed ID: 26850493
[TBL] [Abstract][Full Text] [Related]
2. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.
Mauro FR; Morabito F; Vincelli ID; Petrucci L; Campanelli M; Salaroli A; Uccello G; Petrungaro A; Ronco F; Raponi S; Nanni M; Neri A; Ferrarini M; Guarini AR; Foà R; Gentile M
Leuk Res; 2017 Jun; 57():65-71. PubMed ID: 28292720
[TBL] [Abstract][Full Text] [Related]
4. Prediction of severe infections in chronic lymphocytic leukemia: a simple risk score to stratify patients at diagnosis.
Murru R; Galitzia A; Barabino L; Presicci R; La Nasa G; Caocci G
Ann Hematol; 2024 May; 103(5):1655-1664. PubMed ID: 38236391
[TBL] [Abstract][Full Text] [Related]
5. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract][Full Text] [Related]
6. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Ruchlemer R; Berrebi A; Polliack A;
Eur J Haematol; 2014 Jul; 93(1):29-33. PubMed ID: 24547751
[TBL] [Abstract][Full Text] [Related]
8. The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.
Francis S; Karanth M; Pratt G; Starczynski J; Hooper L; Fegan C; Pepper C; Valcarcel D; Milligan DW; Delgado J
Cancer; 2006 Sep; 107(5):1023-33. PubMed ID: 16862572
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
Svensson T; Höglund M; Cherif H
Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
11. IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.
Ishdorj G; Streu E; Lambert P; Dhaliwal HS; Mahmud SM; Gibson SB; Banerji V; Marshall AJ; Johnston JB
Blood Adv; 2019 Jul; 3(14):2188-2198. PubMed ID: 31324639
[TBL] [Abstract][Full Text] [Related]
12. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
[TBL] [Abstract][Full Text] [Related]
13. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors for Chronic Lymphocytic Leukemia.
Chen C; Puvvada S
Curr Hematol Malig Rep; 2016 Feb; 11(1):37-42. PubMed ID: 26748932
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic significance of serum immunoglobulin paraprotein in chronic lymphocytic leukemia].
Yang S; Zou ZJ; Li YY; Zhang LN; Han TT; Fan L; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):795-800. PubMed ID: 23384896
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia].
Zhu HY; Wang L; Qiao J; Zou YX; Xia Y; Wu W; Cao L; Liang JH; Fan L; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):392-397. PubMed ID: 29779348
[No Abstract] [Full Text] [Related]
18. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Amaya-Chanaga CI; Rassenti LZ
Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
[TBL] [Abstract][Full Text] [Related]
19. Genotypic characterization and multivariate survival analysis of chronic lymphocytic leukemia in Taiwan.
Chen PM; Lin SH; Fan SF; Chiou TJ; Hsieh RK; Yu IT; Liu JH
Acta Haematol; 1997; 97(4):196-204. PubMed ID: 9158661
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
